MA46239A - Mousse pharmaceutique stable - Google Patents

Mousse pharmaceutique stable

Info

Publication number
MA46239A
MA46239A MA046239A MA46239A MA46239A MA 46239 A MA46239 A MA 46239A MA 046239 A MA046239 A MA 046239A MA 46239 A MA46239 A MA 46239A MA 46239 A MA46239 A MA 46239A
Authority
MA
Morocco
Prior art keywords
stable pharmaceutical
pharmaceutical foam
foam
stable
pharmaceutical
Prior art date
Application number
MA046239A
Other languages
English (en)
French (fr)
Inventor
Tamar Auerbach-Nevo
Ashley Deanglis
Israel Nur
Original Assignee
Ethicon Inc
Omrix Biopharmaceuticals Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from IL247810A external-priority patent/IL247810A0/en
Application filed by Ethicon Inc, Omrix Biopharmaceuticals Ltd filed Critical Ethicon Inc
Publication of MA46239A publication Critical patent/MA46239A/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/12—Aerosols; Foams
    • A61K9/122—Foams; Dry foams
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/01—Hydrolysed proteins; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/01—Hydrolysed proteins; Derivatives thereof
    • A61K38/012—Hydrolysed proteins; Derivatives thereof from animals
    • A61K38/014—Hydrolysed proteins; Derivatives thereof from animals from connective tissue peptides, e.g. gelatin, collagen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/36—Blood coagulation or fibrinolysis factors
    • A61K38/363—Fibrinogen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
    • A61K38/482—Serine endopeptidases (3.4.21)
    • A61K38/4833—Thrombin (3.4.21.5)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L26/00—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form
    • A61L26/0009—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form containing macromolecular materials
    • A61L26/0028—Polypeptides; Proteins; Degradation products thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L26/00—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form
    • A61L26/0009—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form containing macromolecular materials
    • A61L26/0028—Polypeptides; Proteins; Degradation products thereof
    • A61L26/0042—Fibrin; Fibrinogen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L26/00—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form
    • A61L26/0009—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form containing macromolecular materials
    • A61L26/0028—Polypeptides; Proteins; Degradation products thereof
    • A61L26/0047—Specific proteins or polypeptides not covered by groups A61L26/0033 - A61L26/0042
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L26/00—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form
    • A61L26/0061—Use of materials characterised by their function or physical properties
    • A61L26/0085—Porous materials, e.g. foams or sponges
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2400/00—Materials characterised by their function or physical properties
    • A61L2400/04—Materials for stopping bleeding

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Materials Engineering (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Hematology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Dispersion Chemistry (AREA)
  • Diabetes (AREA)
  • Dermatology (AREA)
  • Biomedical Technology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Materials For Medical Uses (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
MA046239A 2016-09-14 2017-09-11 Mousse pharmaceutique stable MA46239A (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201662394371P 2016-09-14 2016-09-14
IL247810A IL247810A0 (en) 2016-09-14 2016-09-14 Stable pharmaceutical foam

Publications (1)

Publication Number Publication Date
MA46239A true MA46239A (fr) 2019-07-24

Family

ID=60022140

Family Applications (1)

Application Number Title Priority Date Filing Date
MA046239A MA46239A (fr) 2016-09-14 2017-09-11 Mousse pharmaceutique stable

Country Status (9)

Country Link
EP (1) EP3512502A1 (zh)
JP (1) JP7114597B2 (zh)
KR (1) KR102656742B1 (zh)
CN (1) CN109789091A (zh)
AU (1) AU2017328480A1 (zh)
CA (1) CA3036770A1 (zh)
IL (1) IL265252B2 (zh)
MA (1) MA46239A (zh)
WO (1) WO2018051325A1 (zh)

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2492458A (en) 1944-12-08 1949-12-27 Jr Edgar A Bering Fibrin foam
CH264752A (de) * 1947-06-03 1949-10-31 Hoffmann La Roche Verfahren zur Herstellung von Trägern für Arzneimittel.
JPS5814813B2 (ja) * 1976-11-09 1983-03-22 味の素株式会社 起泡剤及びその製造法
US6454787B1 (en) 1998-12-11 2002-09-24 C. R. Bard, Inc. Collagen hemostatic foam
DE60020330T2 (de) 1999-07-21 2005-11-03 Imedex Biomateriaux Eiweissschaum klebstoff zur chirurgischen und/oder therapeutischen verwendung
CA2399211A1 (en) 2000-02-25 2001-08-30 David Sierra Foam-forming wound dressing
CN1250605C (zh) 2001-03-26 2006-04-12 拜尔公司 具有显著剪切变稀行为的聚碳酸酯
US8741335B2 (en) 2002-06-14 2014-06-03 Hemcon Medical Technologies, Inc. Hemostatic compositions, assemblies, systems, and methods employing particulate hemostatic agents formed from hydrophilic polymer foam such as Chitosan
US6749842B2 (en) * 2002-01-24 2004-06-15 Midwest Grain Products Liquid foam builder containing hydrolyzed grain protein
WO2009023745A1 (en) 2007-08-14 2009-02-19 The Regents Of The University Of California Mesocellular oxide foams as hemostatic compositions and methods of use
JP2012512812A (ja) * 2007-12-28 2012-06-07 クロス・バイオサージェリー・アクチェンゲゼルシャフト フィブリンフォームに組込まれたｐｄｇｆ融合タンパク質
CN102014973A (zh) * 2008-02-29 2011-04-13 弗罗桑医疗设备公司 用于促进止血和/或伤口愈合的装置
AU2009220808B2 (en) * 2008-03-03 2014-01-16 Omrix Biopharmaceuticals Ltd. A gelatin sponge comprising an active ingredient, its preparation and use
US8753670B2 (en) 2008-03-26 2014-06-17 Baxter International Inc. Fibrin foam and process
US8512740B2 (en) 2008-03-26 2013-08-20 Baxter International Inc. Fibrin foam and process for making
US20110036133A1 (en) * 2008-04-18 2011-02-17 N. V. Organon Purification of protein hydrolysate and the result and products
US20100021527A1 (en) 2008-07-25 2010-01-28 Chunlin Yang Collagen-related peptides and uses thereof and hemostatic foam substrates
US8778883B2 (en) 2009-11-13 2014-07-15 Industrial Technology Research Institute Foamy biomaterial for biological tissue repair
RU2013155713A (ru) 2011-07-06 2015-08-20 Профибрикс Бв Составы для лечения ран
US8680240B1 (en) 2012-11-01 2014-03-25 George David Falus Tissue sealant for use in non-compressible hemorrhage
AU2013353931B2 (en) 2012-12-07 2016-12-08 Baxter Healthcare S.A. Hemostatic foam
CN105543315A (zh) * 2015-12-16 2016-05-04 陕西科技大学 胶原蛋白类发泡剂、其复配改性发泡剂以及二者的制备方法

Also Published As

Publication number Publication date
IL265252B2 (en) 2023-11-01
JP2019526646A (ja) 2019-09-19
CN109789091A (zh) 2019-05-21
IL265252B1 (en) 2023-07-01
IL265252A (en) 2019-05-30
WO2018051325A1 (en) 2018-03-22
AU2017328480A1 (en) 2019-03-14
CA3036770A1 (en) 2018-03-22
EP3512502A1 (en) 2019-07-24
JP7114597B2 (ja) 2022-08-08
KR20190054110A (ko) 2019-05-21
KR102656742B1 (ko) 2024-04-15

Similar Documents

Publication Publication Date Title
BR112018009951A2 (pt) fármaco oftálmico
DK3529248T3 (da) Farmaceutiske sammensætninger
DK3328880T3 (da) Terapeutiske midler
DK3479819T3 (da) Stabilt væskeformigt farmaceutisk præparat
MA46334A (fr) Composition pharmaceutique liquide
MA50541A (fr) Formulations pharmaceutiques
DK3529240T3 (da) Farmaceutiske forbindelser
MA42303A (fr) Formulations pharmaceutiques
MA46867A (fr) Formulations pharmaceutiques
MA43705A (fr) Formulation pharmaceutique
MA43375A (fr) Mousse minérale ultra-légère
DK3634377T3 (da) Farmaceutisk formulering
DK3199161T3 (da) Farmaceutisk præparat
DK3525897T3 (da) Spilsystem
MA44987A (fr) Formulations de médicaments améliorées
DK3463345T3 (da) Farmaceutiske kombinationer
MA47516A (fr) Composition pharmaceutique
DK3679010T3 (da) Kulsyre-additionsprodukter
MA42964A (fr) Préparation pharmaceutique anti-vieillissement
MA49822A (fr) Combinaison pharmaceutique comprenant du ponesimod
IL266537A (en) pharmaceutical preparation
DK3280447T3 (da) Farmaceutiske formuleringer
ZA201807851B (en) Pharmaceutical formulation
DK3601277T3 (da) Farmaceutisk formulering
CL2016002705A1 (es) Formulación agroquímica